Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.
Journal
Journal of breath research
ISSN: 1752-7163
Titre abrégé: J Breath Res
Pays: England
ID NLM: 101463871
Informations de publication
Date de publication:
27 03 2019
27 03 2019
Historique:
pubmed:
29
1
2019
medline:
24
12
2019
entrez:
29
1
2019
Statut:
epublish
Résumé
fractional exhaled nitric oxide (FeNO) is a non-invasive and reproducible marker of nitrosative stress and lung inflammation. More recently, FeNO has been proposed as a marker of severity of idiopathic pulmonary fibrosis (IPF) and systemic sclerosis associated ILD. to evaluate the role of FeNO in the diagnostic pathway of ILDs. according to ERS guidelines for exhaled biomarkers in lung diseases, FeNO at multiple flow-rates (50-100-150 and 350 ml s all ILD groups reported higher levels of FeNO 150-350 ml s patients affected by ILD reported increased FeNO 150-350 ml s
Sections du résumé
BACKGROUND
fractional exhaled nitric oxide (FeNO) is a non-invasive and reproducible marker of nitrosative stress and lung inflammation. More recently, FeNO has been proposed as a marker of severity of idiopathic pulmonary fibrosis (IPF) and systemic sclerosis associated ILD.
AIM AND OBJECTIVES
to evaluate the role of FeNO in the diagnostic pathway of ILDs.
METHODS
according to ERS guidelines for exhaled biomarkers in lung diseases, FeNO at multiple flow-rates (50-100-150 and 350 ml s
RESULTS
all ILD groups reported higher levels of FeNO 150-350 ml s
CONCLUSIONS
patients affected by ILD reported increased FeNO 150-350 ml s
Identifiants
pubmed: 30690441
doi: 10.1088/1752-7163/ab0233
doi:
Substances chimiques
Nitric Oxide
31C4KY9ESH
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM